[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519311":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":34,"responsibleParty":49,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":10,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":10,"maxAge":10,"enrollmentInfo":60,"targetDuration":63,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Samsung Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ATG\u002FLD-PTCy group",null,"Patients undergoing haploidentical hematopoietic stem cell transplantation with ATG and low-dose post-transplant cyclophosphamide conditioning at the department of pediatrics, Samsung Medical Center",[13],"Drug: ATG-LDPTCy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DRUG","ATG-LDPTCy","antithymocyte globulin with low dose post-transplant cyclophosphamide",[9],[21],{"name":22,"affiliation":5,"role":23},"Keon Hee Yoo, Professor","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Hee Young Ju","CONTACT","82-02-3410-0865","hyju320@gmail.com",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Min Suk Rheu","82-02-3410-3607","minsuk.rheu@sbri.co.kr",[35],{"facility":5,"status":36,"city":37,"state":10,"zip":10,"country":38,"countryCode":10,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Seoul","South Korea",{"type":40,"coordinates":41},"Point",[42,43],126.9784,37.566,{"lat":43,"lon":42},[46],{"name":26,"role":27,"phone":47,"phoneExt":10,"email":48},"82-10-3410-0865","heeyoung.ju@samsung.com",{"type":23,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"KeonHee Yoo","Professor","100519311","haploidentical-hematopoietic-stem-cell-transplantation-with-early-atg-and-low-dose-post-transplant-cyclophosphamide-100519311",false,"NCT06041893","Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide","Haploidentical Hematopoietic Stem Cell Transplantation With Early Antithymocyte Globulin and Low Dose Post-transplant Cyclophosphamide","Inclusion Criteria:\n\n* Patients undergoing haploidentical hematopoietic stem cell transplantation with ATG and low-dose post-transplant cyclophosphamide conditioning at the department of pediatrics, Samsung Medical Center.\n\nExclusion Criteria:\n\n* A clinical trial subject (legal representative, if applicable) who do not consent or is unable to give written consent.","ALL",{"count":61,"type":62},20,"ESTIMATED","1 Year","OBSERVATIONAL","Aim of this study is to investigate the effect of early administration of anti-thymocyte globulin and post-transplant low-dose cyclophosphamide in heploidentical hematopoietic stem cell transplantation.",[67],"Haploidentical Hematopoietic Stem Cell Transplantation",[69,70],"post transplant cyclophosphamide","antithymocyte globulin","2024-12-02",{"date":73,"type":74},"2024-12-03","ACTUAL",{"date":76,"type":74},"2023-05-29",{"date":78,"type":62},"2025-12-31",{"name":5,"class":6},1]